| 1 | [SID50085961] | Active | Potency | 0.0082 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor [AID588790, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 50085961 | | CID | 5807 | | Outcome | Active | | Potency | 0.0082 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor | | AID | 588790 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 2 | [SID50085961] | Active | Potency | 0.0082 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor [AID588790, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 50085961 | | CID | 5807 | | Outcome | Active | | Potency | 0.0082 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor | | AID | 588790 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 3 | [SID50085961] | Active | Potency | 0.0082 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor [AID588790, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 50085961 | | CID | 5807 | | Outcome | Active | | Potency | 0.0082 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor | | AID | 588790 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 4 | [SID50085961] | Active | Potency | 0.0082 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor [AID588790, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 50085961 | | CID | 5807 | | Outcome | Active | | Potency | 0.0082 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor | | AID | 588790 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 5 | [SID50085961] | Active | Potency | 0.1836 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation [AID588463, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 50085961 | | CID | 5807 | | Outcome | Active | | Potency | 0.1836 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation | | AID | 588463 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 6 | [SID50085961] | Active | Potency | 0.1836 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation [AID588463, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 50085961 | | CID | 5807 | | Outcome | Active | | Potency | 0.1836 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation | | AID | 588463 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 7 | [SID50085961] | Active | Potency | 0.1836 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation [AID588463, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 50085961 | | CID | 5807 | | Outcome | Active | | Potency | 0.1836 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation | | AID | 588463 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 8 | [SID50085961] | Active | Potency | 0.1836 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation [AID588463, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 50085961 | | CID | 5807 | | Outcome | Active | | Potency | 0.1836 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation | | AID | 588463 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 9 | [SID103676191] | Active | EC50 | 0.24 | Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting [AID637823, Type: Literature] | Beta-2 adrenergic receptor [gi:296439450] |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103676191 | | CID | 5807 | | Outcome | Active | | EC50 | 0.24 [uM] | | BioAssay | Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting | | AID | 637823 | | BioAssay type | Literature | | Target | Beta-2 adrenergic receptor [gi:296439450] | | PubMed | 22182578 | | Data Table |  |
|
| 10 | [SID103676191] | Active | EC50 | 0.24 | Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting [AID637823, Type: Literature] | Beta-2 adrenergic receptor [gi:296439450] |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103676191 | | CID | 5807 | | Outcome | Active | | EC50 | 0.24 [uM] | | BioAssay | Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting | | AID | 637823 | | BioAssay type | Literature | | Target | Beta-2 adrenergic receptor [gi:296439450] | | PubMed | 22182578 | | Data Table |  |
|
| 11 | [SID103676191] | Active | EC50 | 0.24 | Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting [AID637823, Type: Literature] | Beta-2 adrenergic receptor [gi:296439450] |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103676191 | | CID | 5807 | | Outcome | Active | | EC50 | 0.24 [uM] | | BioAssay | Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting | | AID | 637823 | | BioAssay type | Literature | | Target | Beta-2 adrenergic receptor [gi:296439450] | | PubMed | 22182578 | | Data Table |  |
|
| 12 | [SID103676191] | Active | EC50 | 0.24 | Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting [AID637823, Type: Literature] | Beta-2 adrenergic receptor [gi:296439450] |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103676191 | | CID | 5807 | | Outcome | Active | | EC50 | 0.24 [uM] | | BioAssay | Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting | | AID | 637823 | | BioAssay type | Literature | | Target | Beta-2 adrenergic receptor [gi:296439450] | | PubMed | 22182578 | | Data Table |  |
|
| 13 | [SID17388957] | Active | Potency | 0.3981 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 [AID938, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17388957 | | CID | 5807 | | Outcome | Active | | Potency | 0.3981 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 | | AID | 938 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 14 | [SID17388957] | Active | Potency | 0.3981 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 [AID938, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17388957 | | CID | 5807 | | Outcome | Active | | Potency | 0.3981 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 | | AID | 938 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 15 | [SID17388957] | Active | Potency | 0.3981 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 [AID938, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 17388957 | | CID | 5807 | | Outcome | Active | | Potency | 0.3981 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 | | AID | 938 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 16 | [SID103676191] | Active | Ki | 0.501 | Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells [AID637822, Type: Literature] | Beta-2 adrenergic receptor [gi:296439450] |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103676191 | | CID | 5807 | | Outcome | Active | | Ki | 0.501 [uM] | | BioAssay | Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells | | AID | 637822 | | BioAssay type | Literature | | Target | Beta-2 adrenergic receptor [gi:296439450] | | PubMed | 22182578 | | Data Table |  |
|
| 17 | [SID103676191] | Active | Ki | 0.501 | Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells [AID637822, Type: Literature] | Beta-2 adrenergic receptor [gi:296439450] |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103676191 | | CID | 5807 | | Outcome | Active | | Ki | 0.501 [uM] | | BioAssay | Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells | | AID | 637822 | | BioAssay type | Literature | | Target | Beta-2 adrenergic receptor [gi:296439450] | | PubMed | 22182578 | | Data Table |  |
|
| 18 | [SID103676191] | Active | Ki | 0.501 | Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells [AID637822, Type: Literature] | Beta-2 adrenergic receptor [gi:296439450] |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103676191 | | CID | 5807 | | Outcome | Active | | Ki | 0.501 [uM] | | BioAssay | Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells | | AID | 637822 | | BioAssay type | Literature | | Target | Beta-2 adrenergic receptor [gi:296439450] | | PubMed | 22182578 | | Data Table |  |
|
| 19 | [SID103676191] | Active | Ki | 0.501 | Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells [AID637822, Type: Literature] | Beta-2 adrenergic receptor [gi:296439450] |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103676191 | | CID | 5807 | | Outcome | Active | | Ki | 0.501 [uM] | | BioAssay | Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells | | AID | 637822 | | BioAssay type | Literature | | Target | Beta-2 adrenergic receptor [gi:296439450] | | PubMed | 22182578 | | Data Table |  |
|
| 20 | [SID56320928] | Active | EC50 | 0.822 | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 [AID588763, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 56320928 | | CID | 5807 | | Outcome | Active | | EC50 | 0.822 [uM] | | BioAssay | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 | | AID | 588763 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 21 | [SID56320928] | Active | EC50 | 0.822 | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 [AID588763, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 56320928 | | CID | 5807 | | Outcome | Active | | EC50 | 0.822 [uM] | | BioAssay | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 | | AID | 588763 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 22 | [SID56320928] | Active | EC50 | 0.822 | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 [AID588763, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 56320928 | | CID | 5807 | | Outcome | Active | | EC50 | 0.822 [uM] | | BioAssay | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 | | AID | 588763 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 23 | [SID56320928] | Active | EC50 | 0.822 | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 [AID588763, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 56320928 | | CID | 5807 | | Outcome | Active | | EC50 | 0.822 [uM] | | BioAssay | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 | | AID | 588763 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 24 | [SID56320927] | Active | EC50 | 0.828 | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 [AID588763, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 56320927 | | CID | 5807 | | Outcome | Active | | EC50 | 0.828 [uM] | | BioAssay | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 | | AID | 588763 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 25 | [SID56320927] | Active | EC50 | 0.828 | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 [AID588763, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 56320927 | | CID | 5807 | | Outcome | Active | | EC50 | 0.828 [uM] | | BioAssay | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 | | AID | 588763 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 26 | [SID56320927] | Active | EC50 | 0.828 | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 [AID588763, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 56320927 | | CID | 5807 | | Outcome | Active | | EC50 | 0.828 [uM] | | BioAssay | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 | | AID | 588763 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 27 | [SID56320927] | Active | EC50 | 0.828 | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 [AID588763, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 56320927 | | CID | 5807 | | Outcome | Active | | EC50 | 0.828 [uM] | | BioAssay | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 | | AID | 588763 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 28 | [SID50085961] | Active | Potency | 7.0795 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 50085961 | | CID | 5807 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 29 | [SID50085961] | Active | Potency | 7.0795 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 50085961 | | CID | 5807 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 30 | [SID50085961] | Active | Potency | 7.0795 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 50085961 | | CID | 5807 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 31 | [SID50085961] | Active | Potency | 7.0795 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 50085961 | | CID | 5807 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 32 | [SID103676191] | Active | IC50 | 7.94328 | Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay [AID524796, Type: Literature] | |   View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103676191 | | CID | 5807 | | Outcome | Active | | IC50 | 7.94328 [uM] | | BioAssay | Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay | | AID | 524796 | | BioAssay type | Literature | | Target | | | PubMed | 19734910 | | Data Table |  |
|
| 33 | [SID50085961] | Active | Potency | 11.2202 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 50085961 | | CID | 5807 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 34 | [SID26747558] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26747558 | | CID | 5807 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 35 | [SID50106483] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 50106483 | | CID | 5807 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 36 | [SID50106527] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 50106527 | | CID | 5807 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 37 | [SID50085961] | Active | IC50 | 100 | High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media [AID449762, Type: confirmatory] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 50085961 | | CID | 5807 | | Outcome | Active | | IC50 | 100 [uM] | | BioAssay | High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media | | AID | 449762 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID8149393] | Active | | | Cellular toxicity caused by inducible expressing of N-terminal huntingtin with expanded ployglutamine repeat (Htt-N63-148Q) in PC12 cells (ROSShtt) [AID1590, Type: other] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 8149393 | | CID | 5807 | | Outcome | Active | | BioAssay | Cellular toxicity caused by inducible expressing of N-terminal huntingtin with expanded ployglutamine repeat (Htt-N63-148Q) in PC12 cells (ROSShtt) | | AID | 1590 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID8149393] | Active | | | Screen for compounds that suppress mutant SOD1-mediated cell death (mSODtox) [AID1601, Type: other] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 8149393 | | CID | 5807 | | Outcome | Active | | BioAssay | Screen for compounds that suppress mutant SOD1-mediated cell death (mSODtox) | | AID | 1601 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID50085961] | Active | | | Aqueous Solubility from MLSMR Stock Solutions [AID1996, Type: other] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 50085961 | | CID | 5807 | | Outcome | Active | | BioAssay | Aqueous Solubility from MLSMR Stock Solutions | | AID | 1996 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID56320927] | Active | | | Counterscreen for activators of kallikrein-7 (K7) zymogen: Fluorescence intensity-based biochemical high throughput counterscreen assay for activators that optically interfere with measurement of EDANS-DABCYL fluorescence [AID686952, Type: screening] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 56320927 | | CID | 5807 | | Outcome | Active | | BioAssay | Counterscreen for activators of kallikrein-7 (K7) zymogen: Fluorescence intensity-based biochemical high throughput counterscreen assay for activators that optically interfere with measurement of EDANS-DABCYL fluorescence | | AID | 686952 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID56320928] | Active | | | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 [AID540358, Type: other] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 56320928 | | CID | 5807 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 | | AID | 540358 | | BioAssay type | other | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 43 | [SID56320928] | Active | | | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 [AID540358, Type: other] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 56320928 | | CID | 5807 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 | | AID | 540358 | | BioAssay type | other | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 44 | [SID56320928] | Active | | | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 [AID540358, Type: other] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 56320928 | | CID | 5807 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 | | AID | 540358 | | BioAssay type | other | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 45 | [SID56320928] | Active | | | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 [AID540358, Type: other] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 56320928 | | CID | 5807 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 | | AID | 540358 | | BioAssay type | other | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 46 | [SID56463187] | Active | | | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 [AID540358, Type: other] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 56463187 | | CID | 5807 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 | | AID | 540358 | | BioAssay type | other | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 47 | [SID56463187] | Active | | | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 [AID540358, Type: other] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 56463187 | | CID | 5807 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 | | AID | 540358 | | BioAssay type | other | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 48 | [SID56463187] | Active | | | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 [AID540358, Type: other] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 56463187 | | CID | 5807 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 | | AID | 540358 | | BioAssay type | other | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 49 | [SID56463187] | Active | | | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 [AID540358, Type: other] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 56463187 | | CID | 5807 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 | | AID | 540358 | | BioAssay type | other | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 50 | [SID56320927] | Active | | | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 [AID540358, Type: other] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 56320927 | | CID | 5807 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 | | AID | 540358 | | BioAssay type | other | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|